35.34
前日終値:
$35.80
開ける:
$35.34
24時間の取引高:
1.78M
Relative Volume:
0.75
時価総額:
$5.38B
収益:
$3.44B
当期純損益:
$-8.30M
株価収益率:
-237.66
EPS:
-0.1487
ネットキャッシュフロー:
$43.30M
1週間 パフォーマンス:
+5.08%
1か月 パフォーマンス:
-13.85%
6か月 パフォーマンス:
+13.85%
1年 パフォーマンス:
-18.78%
Bruker Corp Stock (BRKR) Company Profile
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BRKR
Bruker Corp
|
35.34 | 5.45B | 3.44B | -8.30M | 43.30M | -0.1487 |
|
ABT
Abbott Laboratories
|
104.57 | 182.16B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
332.68 | 125.39B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.67 | 112.84B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
70.17 | 103.71B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.10 | 48.01B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-10 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | 開始されました | Goldman | Sell |
| 2025-11-20 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-12-19 | 開始されました | Guggenheim | Buy |
| 2024-12-10 | 開始されました | UBS | Neutral |
| 2024-12-05 | アップグレード | Goldman | Sell → Neutral |
| 2024-10-15 | 開始されました | Barclays | Overweight |
| 2024-09-30 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-02-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2022-10-21 | 開始されました | UBS | Buy |
| 2022-08-22 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-06-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2021-02-05 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | 開始されました | Goldman | Sell |
| 2020-11-16 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | ダウングレード | Cleveland Research | Buy → Neutral |
| 2020-04-02 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | ダウングレード | Needham | Strong Buy → Hold |
| 2020-03-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-09-26 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | アップグレード | Goldman | Sell → Neutral |
| 2019-06-24 | 繰り返されました | Needham | Strong Buy |
| 2019-06-21 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-30 | 開始されました | Wolfe Research | Peer Perform |
| 2019-05-06 | 繰り返されました | Needham | Strong Buy |
| 2019-05-03 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | アップグレード | UBS | Sell → Neutral |
| 2019-04-12 | アップグレード | Deutsche Bank | Hold → Buy |
| 2019-02-12 | 繰り返されました | BTIG Research | Buy |
| 2019-01-03 | 開始されました | Needham | Strong Buy |
すべてを表示
Bruker Corp (BRKR) 最新ニュース
Vanguard disaggregates holdings; reports 0 shares in Bruker (NYSE: BRKR) - Stock Titan
Bruker introduces analytical and automation innovations at analytica 2026 - Select Science
Bruker (BRKR) Stock Is Up, What You Need To Know - Yahoo! Finance Canada
Here’s Why Bruker’s (BRKR) Positive Momentum Returned in Q4 - Yahoo Finance
Bruker Corporation (NASDAQ:BRKR) Declares Quarterly Dividend of $0.05 - MarketBeat
Assessing Bruker (BRKR) Valuation After Steep Multi‑Period Share Price Declines - Yahoo Finance
Will Bruker (BRKR) be Able to Rebound? - Insider Monkey
Bruker (NASDAQ: BRKR) EVP Mark Munch exercises options and sells 2,000 shares - Stock Titan
Bruker Corporation $BRKR Shares Purchased by Aquatic Capital Management LLC - MarketBeat
Bruker Corp Stock (ISIN: US1167941087) Faces Rising Short Interest Amid Investor Scrutiny - AD HOC NEWS
Callodine Capital Management LP Makes New $1.11 Million Investment in Bruker Corporation $BRKR - MarketBeat
Mark R Munch reports multiple share sales (BRKR) under Rule 144 - Stock Titan
Bruker Corp (BRKR) Trading Down 3.62% on Mar 13 - GuruFocus
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics and Performance Challenges - Markets Mojo
Bruker Makes Acquisitions; LeddarTech Added to Nasdaq: Week in Brief: 1/5/24 - Photonics Spectra
Natixis Advisors LLC Boosts Stock Position in Bruker Corporation $BRKR - MarketBeat
Bruker Corporation $BRKR Position Increased by Ceredex Value Advisors LLC - MarketBeat
Is Bruker (BRKR) Quietly Recasting Its Competitive Moat With Spatial Biology And Proteomics Upgrades? - simplywall.st
These analysts cut their forecasts on Bruker following Q4 results - MSN
Citigroup Inc. Sells 29,083 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corporation $BRKR Shares Acquired by Rhenman & Partners Asset Management AB - MarketBeat
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know - Finviz
RSI Alert: Bruker (BRKR) Now Oversold - Nasdaq
Orbis group reports 16.13M shares in Bruker (BRKR) as 10.6% ownership - Stock Titan
Research Tools & Consumables Stocks Q4 In Review: Bruker (NASDAQ:BRKR) Vs Peers - Yahoo Finance
Bruker Corp To Go Ex-Dividend On March 23rd, 2026 With 0.05 USD Dividend Per Share - 富途牛牛
BRKRP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BRKR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $49 - 富途牛牛
Artisan Partners Limited Partnership Invests $13.69 Million in Bruker Corporation $BRKR - MarketBeat
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Assessing Bruker (BRKR) Valuation After New Spatial Biology Platforms And Collaboration Updates - simplywall.st
BRKR PE Ratio & Valuation, Is BRKR Overvalued - Intellectia AI
Beyond the Balance Sheet: What SWOT Reveals About Bruker Corp (B - GuruFocus
Bruker (NASDAQ: BRKR) outlines 2025 business segments, risks and $2.57B backlog - Stock Titan
Bruker (BRKR): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics With the Launch of CellScape XR - 富途牛牛
Is Bruker (BRKR) Now Offering Value After A Prolonged Share Price Slump? - Yahoo Finance
Bruker Corporation (NASDAQ:BRKR) Given Average Rating of "Hold" by Brokerages - MarketBeat
New Bruker tool targets 3,000-patient tumor study in spatial proteomics - Stock Titan
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR - Yahoo Finance
Reasons Why Bruker Corporation (BRKR) Appears So Attractive - Finviz
Inside Bruker and Noetik’s push toward 1B mapped human cells - Stock Titan
Bruker unveils spatial biology platforms at AGBT conference - Investing.com
Bruker unveils spatial biology platforms at AGBT conference By Investing.com - Investing.com Canada
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology – Company AnnouncementFT.com - Financial Times
Bruker announces board changes and declares quarterly dividend By Investing.com - Investing.com South Africa
Bruker announces board changes and declares quarterly dividend - Investing.com
Envestnet Asset Management Inc. Sells 43,490 Shares of Bruker Corporation $BRKR - MarketBeat
3D Protein Structure Analysis Market Report 2026 Featuring - GlobeNewswire
3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players - Yahoo Finance UK
Bruker Corp (BRKR) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):